These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 6100274)

  • 1. Strategies for prevention and control of hepatitis B and hepatocellular carcinoma.
    Sobeslavsky O
    IARC Sci Publ; 1984; (63):271-8. PubMed ID: 6100274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B vaccination: an important method of preventing HBV-related hepatocellular carcinoma.
    Zanetti A
    Ital J Gastroenterol; 1992 Feb; 24(2):100-2. PubMed ID: 1315589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hepatocellular carcinoma, hepatitis B virus and the immune system].
    Grob PJ
    Schweiz Med Wochenschr; 1986 Aug; 116(34):1133-45. PubMed ID: 3020684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot study on universal immunization of newborn infants in an area of hepatitis B virus and primary hepatocellular carcinoma prevalence with a low dose of hepatitis B vaccine.
    Sun TT; Chu YR; Ni ZQ; Lu JH; Huang F; Ni ZP; Pei XF; Yu ZI; Liu GT
    J Cell Physiol Suppl; 1986; 4():83-90. PubMed ID: 3018008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus and the control of hepatocellular carcinoma.
    Blumberg BS
    IARC Sci Publ; 1984; (63):243-61. PubMed ID: 6100273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and compliance of HBV vaccination trial on newborns to prevent hepatocellular carcinoma and 5-year results of its pilot study.
    Sun Z; Zhu Y; Stjernsward J; Hilleman M; Collins R; Zhen Y; Hsia CC; Lu J; Huang F; Ni Z
    Cancer Detect Prev; 1991; 15(4):313-8. PubMed ID: 1665400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The relation of infection with the hepatitis B-agent to primary hepatic carcinoma (author's transl)].
    Blumberg BS; Larouzé B; London WT; Werner B; Hesser JE; Millman I; Saimot G; Payet M
    Leber Magen Darm; 1976 Dec; 6(6):309-15. PubMed ID: 190499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatocellular carcinoma: a preventable cancer].
    Viviani S; Jack A; Bah E; Montesano R
    Epidemiol Prev; 1997; 21(2):129-36. PubMed ID: 9378180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B vaccine: clinical experience.
    Tron F
    IARC Sci Publ; 1984; (63):279-95. PubMed ID: 6242147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of hepatocellular carcinoma by immunization against hepatitis B.
    Zuckerman AJ
    Int Rev Exp Pathol; 1985; 27():59-81. PubMed ID: 3017884
    [No Abstract]   [Full Text] [Related]  

  • 11. [Efficacy of hepatitis B vaccination on hepatitis B prevention and on hepatocellular carcinoma].
    Li RC; Yang JY; Gong J; Li YP; Huang ZN; Fang KX; Xu ZY; Liu CB; Zhao K; Zhuang H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):385-7. PubMed ID: 15231157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B vaccination: disease and cancer prevention-a Taiwanese experience.
    Chang MH
    Clin Liver Dis; 2010 Aug; 14(3):521-30. PubMed ID: 20638029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence.
    Hung HF; Chen TH
    Vaccine; 2009 Nov; 27(48):6770-6. PubMed ID: 19735755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Strategies for the prevention of hepatocellular carcinoma in the context of chronic viral hepatitis].
    Schott E; Bergk A; Berg T
    Z Gastroenterol; 2008 Jan; 46(1):69-80. PubMed ID: 18188819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Report of the OAU/STRC Ad Hoc Committee on Hepatitis B Vaccination in Africa.
    IARC Sci Publ; 1984; (63):393-401. PubMed ID: 6100277
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention of hepatocellular carcinoma by universal vaccination against hepatitis B virus: the effect and problems.
    Chang MH; Chen TH; Hsu HM; Wu TC; Kong MS; Liang DC; Ni YH; Chen CJ; Chen DS;
    Clin Cancer Res; 2005 Nov; 11(21):7953-7. PubMed ID: 16278421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B: evolving epidemiology and implications for control.
    Margolis HS; Alter MJ; Hadler SC
    Semin Liver Dis; 1991 May; 11(2):84-92. PubMed ID: 1832236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus and the prevention of primary cancer of the liver.
    Blumberg BS; London WT
    J Natl Cancer Inst; 1985 Feb; 74(2):267-73. PubMed ID: 2983134
    [No Abstract]   [Full Text] [Related]  

  • 19. Control of hepatocellular carcinoma through hepatitis B vaccination in areas of high endemicity: perspectives for global liver cancer prevention.
    Plymoth A; Viviani S; Hainaut P
    Cancer Lett; 2009 Dec; 286(1):15-21. PubMed ID: 19836128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatitis B--a viral oncogene?].
    Weis NM; Krogsgaard K
    Ugeskr Laeger; 2002 Dec; 164(50):5940-4. PubMed ID: 12553116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.